Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for postoperative delirium after hepatectomy
ChiCTR2600133191Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in postoperative delirium (POD) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Incidence of postoperative delirium and Expression of exosomal miR-192-5p. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2600133191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133191.